Stealth AXiS Surgical System with Stealth AXiS Spine clinical application
K253381Medtronic Navigation, Inc. · cleared 2026-02-12 · product code OLO · Neurology
Premarket evidence — what FDA accepted
source quote (p.6)
“The Stealth AXIS™ Surgical System is a computer-assisted surgery system that is composed of a platform, clinical application, surgical instruments, and a referencing system (which includes patient and instrument trackers). With the addition of the Stealth AXIS™ Autopilot to the Stealth AXIS™ Core, the Stealth AXIS™ Surgical System becomes a robotic-assisted surgery system.”
source quote (p.12)
“The auto-planning feature in the Stealth AXIS Spine clinical application uses Artificial Intelligence (AI) to automate pedicle screw placement for spinal surgeries, providing patient-specific recommendations for select Medtronic screw types. This feature employs a Siamese Neural Network to compare candidate screw placements to expert standards, using inputs of deep learning-based spine segmentation and rule-based spinal features algorithms. The Automatic Spine Segmentation feature in the Stealth AXiS Spine clinical application uses deep learning AI to automatically segment vertebrae from CT and CBCT (O-arm) images, supporting planning and guidance for spine surgery. This locked UNet-based model distinguishes vertebrae in 3D images, with its vertebral segmentation dependent on image quality and then user verification. The network was trained and validated using internal and public datasets. employing patch-wise training and early stopping to prevent overfitting.”
source quote (p.12)
“The AI model is locked and does not update after deployment.”
Validation studies (2)
Bench
sample size not stated
endpoints: 3D positional accuracy; trajectory angle accuracy
standards: AAMI ES60601-1:2005/AMD1:2012, AAMI ES60601;1:2005/AMD2:2021, IEC 60601-1-2:2014+ A1:2020
Retrospective clinical
sample size not stated
endpoints: screw placement similarity to expert; vertebrae segmentation accuracy
Reported performance (2 observations)
source quote (p.11)
“Under representative worst-case configuration, the Stealth AXIS Surgical System with Stealth AXIS Spine clinical application has demonstrated performance in 3D positional accuracy with a mean error " 2.0 mm”
source quote (p.11)
“and in trajectory angle accuracy with a mean error of 2.0 degrees.”
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
- recall_reason_pattern
Software/algorithm-related recall in product code OLO (Medtronic Navigation, Inc., initiated 2024-08-22): "Due to two software anomalies that can occur within a spine procedure. Two issues are: 1. Navigation Orientation - when lateral orientation radiographic images are taken, informat" Recalling firm matches this device's applicant.
first seen 2026-07-08 · recall res_event_number:95283
- recall_reason_pattern
Software/algorithm-related recall in product code OLO (, initiated 2025-12-10): "Software errors that can result in incorrect surgical instrument positioning during spinal surgery." Recalling firm is another firm in the same product code.
first seen 2026-07-08 · recall res_event_number:98199
- recall_reason_pattern
Software/algorithm-related recall in product code OLO (Tornier S.A.S. 161 Rue Lavoisier Montbonnot-Saint-Martin France, initiated 2025-03-05): "Stryker identified an elevated complaint rate related to difficulties using the Blueprint Mixed Reality Guidance Instrumentation system is multifactorial, but in each instance proh" Recalling firm is another firm in the same product code.
first seen 2026-07-08 · recall res_event_number:96437
- recall_reason_pattern
Software/algorithm-related recall in product code OLO (, initiated 2024-07-17): "Software anomalies which can result in two separate issues: A lagging screen display during a navigated procedure; or the potential for a mismatch between the navigated screw and t" Recalling firm is another firm in the same product code.
first seen 2026-07-08 · recall res_event_number:95189
Recalls attributed to this device
Recalling firm matches this device's applicant (Medtronic Navigation, Inc.) — same firm and product code, not necessarily this device · initiated 2024-12-04
Due to an increase in complaint that the percutaneous reference pin would not fit into the patient reference frame or percutaneous pin adapter.
recall event 95970 (openFDA)
Recalling firm matches this device's applicant (Medtronic Navigation, Inc.) — same firm and product code, not necessarily this device · initiated 2024-08-22
Due to two software anomalies that can occur within a spine procedure. Two issues are: 1. Navigation Orientation - when lateral orientation radiographic images are taken, information may appear flipped when utilizing the system (180 degree flipped). 2. Pop-up Message - when using CT+Fluouroscopy images with a slice spacing thickness greater than 2mm, the system does not display a pop-up message indicating the slice spacing is not optimal.
recall event 95283 (openFDA)
Recalling firm matches this device's applicant (Medtronic Navigation, Inc.) — same firm and product code, not necessarily this device · initiated 2023-11-28
Their is the potential that the percutaneous pin may have a cross-pin that may render the pin unable to fit into tap cap, or too tight to remove.
recall event 93611 (openFDA)
Recalling firm matches this device's applicant (Medtronic Navigation, Inc.) — same firm and product code, not necessarily this device · initiated 2023-11-28
Their is the potential that the percutaneous pin may have a cross-pin that may render the pin unable to fit into tap cap, or too tight to remove.
recall event 93611 (openFDA)
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device); a recall is shown as device-attributed only when the recall record itself lists this clearance number. Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).
Applicable FDA guidance — what the submission is measured against
FDA guidance documents and guiding principles applicable to 510(k) AI/ML devices in the Neurology panel. A curated reference index, not legal or regulatory advice — each item states its own status, and a draft is never binding.
- Final guidance2026-01Clinical Decision Support Software
Clinical decision support · SaMD (general)
New final guidance issued Jan 2026, superseding the Sept 2022 version; narrows the device-CDS scope. Applies to software that informs clinical management.
- Final guidance2026-01General Wellness: Policy for Low Risk Devices
SaMD (general) · Clinical decision support
Revised final (Jan 2026); now addresses noninvasive products estimating physiologic parameters (SpO2, BP, glucose). Reshapes the device / non-device line for AI wellness features.
- Final guidance2025-09Computer Software Assurance for Production and Quality Management System Software
SaMD (general) · Postmarket
Final (Sept 2025). Covers software used in production/QMS (incl. ML development-pipeline tooling), superseding Section 6 of the 2002 GPSV — not device software functions themselves.
- Final guidance2025-06Cybersecurity in Medical Devices: Quality Management System Considerations and Content of Premarket Submissions
Cybersecurity · Software premarket content
Reissued June 2025 (retitled 'Quality Management System', was Sept 2023 'Quality System'); adds coverage of FD&C Act §524B cyber devices.
- Final guidance2024-12Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions
Predetermined Change Control Plan · AI/ML lifecycle · Software premarket content
Final (Dec 2024). Supersedes the April 2023 AI/ML PCCP draft.
- Final guidance2023-10Electronic Submission Template for Medical Device 510(k) Submissions
Software premarket content
eSTAR has been mandatory for 510(k)s since Oct 2023 — operationally unavoidable, though not AI-specific.
- Final guidance2023-08Off-The-Shelf Software Use in Medical Devices
Software premarket content · SaMD (general)
Final (Aug 2023). Applies when a device incorporates off-the-shelf software components (common in ML stacks).
- Final guidance2023-06Content of Premarket Submissions for Device Software Functions
Software premarket content · SaMD (general)
Final (June 2023); replaced the May 2005 'Software Contained in Medical Devices' guidance. Documentation level drives the software content of the submission.
- Final guidance2022-09Policy for Device Software Functions and Mobile Medical Applications
SaMD (general) · Clinical decision support
Current version Sept 2022. Frames which software functions FDA regulates as devices.
- Final guidance2021-10De Novo Classification Process (Evaluation of Automatic Class III Designation)
De Novo pathway
Final (Oct 2021), issued with the De Novo final rule. Most relevant to first-of-a-kind devices without a predicate (DEN-numbered clearances).
- Final guidance2016-12Postmarket Management of Cybersecurity in Medical Devices
Cybersecurity · Postmarket
- Final guidance2002-01General Principles of Software Validation
SaMD (general) · Software premarket content
Still active except Section 6 (superseded Sept 2025 by the Computer Software Assurance final guidance).
- Draft guidance2025-01Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations
AI/ML lifecycle · Software premarket content · Transparency
Draft as of July 2026 (published Jan 2025); finalization is on CDRH's FY2026 agenda but not yet published. Treat as FDA's stated direction, not a binding expectation.
- Draft guidance2024-08Predetermined Change Control Plans for Medical Devices
Predetermined Change Control Plan · Postmarket
Draft (Aug 2024) extending PCCPs beyond AI to all devices under FD&C §515C; not final as of July 2026.
- Guiding principles2024-06Transparency for Machine Learning-Enabled Medical Devices: Guiding Principles
Transparency · AI/ML lifecycle
- Guiding principles2023-10Predetermined Change Control Plans for Machine Learning-Enabled Medical Devices: Guiding Principles
Predetermined Change Control Plan · AI/ML lifecycle
FDA/Health Canada/MHRA joint principles (Oct 2023); companion to the GMLP and Transparency principles.
- Guiding principles2021-10Good Machine Learning Practice for Medical Device Development: Guiding Principles
AI/ML lifecycle · SaMD (general)
FDA/Health Canada/MHRA joint principles (Oct 2021). Foundational, not a binding guidance; IMDRF issued a related GMLP document Jan 2025.
Applicability is derived from the device's FDA advisory panel and pathway — cross-cutting guidances apply to every AI/ML device; panel-specific ones are flagged. Titles, dates, and links verified against fda.gov as of July 2026.